Resultados de la búsqueda 171-180 de 3473 para anti-TNF drugs

1. Neurología - Ensayos clínicos - Mayo Clinic

   ... treatment. Vismodegib and FAK inhibitor GSK2256098 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. A Study to ...

2. Hematología - Ensayos clínicos - Mayo Clinic

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

3. Medicina interna general - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to test if senescent cells and their secretome contribute to Long-Hauler Syndrome and if a clinical trial of senolytic drugs, which ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... Anti-PD-1/L1 in Patients with Locally Advanced or ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... treatment until disease ...

5. Untitled

   Page 1.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   To assess the efficacy of treatment with checkpoint inhibitors (Pembrolizumab or Nivolumab) in metastatic gastric and esophageal carcinoma through retrospective ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   To assess the efficacy of treatment with checkpoint inhibitors (Pembrolizumab or Nivolumab) in metastatic gastric and esophageal carcinoma through retrospective ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

9. Neurología - Ensayos clínicos - Mayo Clinic

   ... treatment. Vismodegib and FAK inhibitor GSK2256098 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. A Study to ...

10. Neurobiology of Neurodegenerative Diseases Wilfried O Rossoll.